Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9478242 | 0.90 | KMO (0.32) | CHRM1BRD4 | |
| SCHEMBL9032890 | 0.89 | CHRM1 (0.32) | CHRM1RORC | |
| SCHEMBL15779803 | 0.87 | CHRM1 (0.37) | CHRM1CHRM5CHRM3BRD4 | |
| SCHEMBL9477928 | 0.86 | CHRM1 (0.37) | CHRM1CHRM5CHRM3 | |
| SCHEMBL9842340 | 0.85 | CHRM1 (0.38) | CHRM1CHRM5CHRM3RORCBRD4 | |
| SCHEMBL9478774 | 0.85 | CHRM1 (0.38) | CHRM1CHRM5CHRM3 | |
| SCHEMBL12981165 | 0.85 | PIK3CG (0.36) | BRD4TP53MAPTALDH1A1 | |
| SCHEMBL12188290 | 0.84 | HTR1A (0.37) | CHRM1 | |
| SCHEMBL29577537 | 0.83 | CHRM1 (0.36) | CHRM1CHRM5CHRM3 | |
| SCHEMBL38805 | 0.83 | CHRM1 (0.36) | CHRM1CHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4074174-A | — | — | None | — | — | JP | disclosed |
| JP-3204865-A | — | — | None | — | — | JP | disclosed |
| US-8748348-B2 | 3-(3,4-dihydro-2H-benzo [1,4]oxazin-6-yl)-1H-pyrimidin-2,4-dione compounds as herbicides | BASF SE (DE) | 2014-06-10 | — | — | US | disclosed |
| US-8481723-B2 | 3-(3,4-dihydro-2H-benzo [1,4]oxazin-6-yl)-1H-Pyrimidin-2,4-dione compounds as herbicides | BASF SE (DE) | 2013-07-09 | — | — | US | disclosed |
| US-8481723-B2 | 3-(3,4-dihydro-2H-benzo [1,4]oxazin-6-yl)-1H-Pyrimidin-2,4-dione compounds as herbicides | BASF SE (DE) | 2013-07-09 | — | — | US | disclosed |
| EP-2584896-A2 | HERBICIDAL COMPOSITIONS | BASF SE (DE) | 2013-05-01 | — | — | EP | disclosed |
| US-20130102463-A1 | Herbicidal Compositions | BASF SE (DE) | 2013-04-25 | — | — | US | disclosed |
| US-8293979-B2 | Weed controller metabolism proteins, genes, thereof and use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-23 | — | — | US | disclosed |
| US-8293979-B2 | Weed controller metabolism proteins, genes, thereof and use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20120231952-A1 | 3-(3,4-dihydro-2H-benzo [1,4]oxazin-6-yl)-1H-Pyrimidin-2,4-dione compounds as herbicides | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| US-20100184597-A1 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | NAKAJIMA HIROKI | 2010-07-22 | — | — | US | disclosed |
| US-7745699-B2 | Weed controller metabolism proteins, genes thereof and use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-29 | — | — | US | disclosed |
| US-7745699-B2 | Weed controller metabolism proteins, genes thereof and use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-29 | — | — | US | disclosed |
| US-7485777-B2 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-03 | — | — | US | disclosed |
| US-7485777-B2 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-03 | — | — | US | disclosed |
| US-5127935-A | Halogen, phenyl and heterocycle substituents, agricultural use | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-07-07 | — | — | US | disclosed |
| JP-H0474174-A | BENZOOXAZINYLURACIL DERIVATIVE, PREPARATION THEREOF AND HERBICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | SUMITOMO CHEM CO LTD | 1992-03-09 | — | — | JP | disclosed |
| US-5084084-A | Uracil and thiouracil derivatives | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-01-28 | — | — | US | disclosed |
| JP-H03204865-A | URACIL DERIVATIVE AND HERBICIDE | NISSAN CHEM IND LTD | 1991-09-06 | — | — | JP | disclosed |
| EP-0420194-A2 | Uracil derivatives and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184597-A1 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | PPOX, HMBS, COX6B1 | CHRM1 4271/4885CHRM5 3720/4885CHRM3 4208/4885 |
| US-20130102463-A1 | Herbicidal Compositions | PPOX, PAOX, DDT | CHRM1 3450/4885CHRM5 4136/4885CHRM3 3740/4885 |
| US-20120231952-A1 | 3-(3,4-dihydro-2H-benzo [1,4]oxazin-6-yl)-1H-Pyrimidin-2,4-dione compounds as herbicides | UNG, DDT, DPYD | CHRM1 2955/4885CHRM5 3701/4885CHRM3 4049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.